GENFIT (GNFT)
(Delayed Data from NSDQ)
$3.76 USD
+0.02 (0.54%)
Updated May 10, 2024 03:45 PM ET
3-Hold of 5 3
C Value F Growth D Momentum D VGM
Price, Consensus and EPS Surprise
GNFT 3.76 +0.02(0.54%)
Will GNFT be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for GNFT based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for GNFT
GENFIT S.A. Unsponsored ADR (GNFT) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
What Makes GENFIT S.A. Unsponsored ADR (GNFT) a New Buy Stock
GNFT: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for GNFT
GENFIT: Publication of the 2024 Extra-Financial Performance Report (fiscal year 2023)
GENFIT Releases Impactful CSR Performance Report
GENFIT Annual Combined General Meeting of May 22, 2024 — Availability of Preparatory Documents
GENFIT Announces Upcoming Shareholders Meeting
Buy Rating Reiterated for Genfit SA Amidst Promising Clinical Developments and Strong Financial Outlook